{"id":"W2130082562","doi":"10.1136/annrheumdis-2013-204963","title":"Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":152,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Internal medicine; Clinical endpoint; Ankylosing spondylitis; Neutropenia; Randomized controlled trial; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005411485,0.001568643,0.003856992,0.0004458742,0.0005753984,0.001066913,0.0008865412,0.002191142,0.005227061],"category_scores_gemma":[0.002092601,0.0007263647,0.001740762,0.0005518876,0.000967685,0.0009796568,0.0002734418,0.002335491,0.0009097583],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004969346,"about_ca_system_score_gemma":0.001167241,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003914569,"about_ca_topic_score_gemma":0.001000987,"domain_scores_codex":[0.9987134,0.0007616741,0.0001248539,0.0001501964,0.0001376058,0.0001123074],"domain_scores_gemma":[0.9986461,0.0003354533,0.0003684755,0.0001111591,0.0001461496,0.0003926743],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9376094,0.01634443,0.001646967,0.002495666,0.001746439,0.0001058027,0.0001039167,0.0002689514,0.008881632,0.00007261815,0.001347876,0.0293764],"study_design_scores_gemma":[0.9101622,0.08389929,0.00421482,0.00003870853,0.0004806008,0.00007565958,0.00001313817,0.0001371396,0.000402414,0.00003173033,0.000530074,0.00001422597],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9687129,0.01572628,0.001311974,0.0008479206,0.0005923512,0.008124511,0.002200248,0.0002711291,0.002212845],"genre_scores_gemma":[0.9715742,0.009332223,0.003477156,0.001972172,0.001039882,0.007315169,0.002865616,0.00005396177,0.002369627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005411485,"threshold_uncertainty_score":0.02861905,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06819954645693337,"score_gpt":0.3656415064500914,"score_spread":0.297441959993158,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}